98% sensitive and 97% specific in the detection of Atrial Fibrillation 1
Provides a diagnostic yield comparable to a 14-day ambulatory event monitor 2
The most clinically-validated portable ECG solution available
KardiaMobile has delivered more than 40 million ECGs worldwide
The only FDA-cleared devices that detect the 3 most common arrhythmias
1. Lau JK, Lowres N, Neubeck L, Brieger DB, Sy RW, Galloway CD, et al. Int J Cardiol. 2013;165(1):193-4.
2. Narasimha D, Hanna N, Beck H, Chaskes M, Glover R, Gatewood R, et al. Validation of a smartphone-based event recorder for arrhythmia detection. Pacing Clin Electrophysiol. 2018.
KardiaMobile is a convenient way to monitor for AFib recurrence after cardiac surgery.
Lowres N et al., Eur J Cardiothorac Surg, 2016
KardiaMobile smartphone-based ECG monitors added to the 2017 consensus guidelines for patients post-ablation.
HRS Consensus Statement, 2017
Self-monitoring with KardiaMobile improves AFib detection and self-reported quality of life.
iHEART study, J Atr Fibrillation , 2017
Patients are engaged in their own healthcare like never before. Affordable and discrete, patients can take action when they feel a symptom to conveniently self-monitor their heart short or long-term.